Literature DB >> 17052926

Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease.

Antonello Pietrangelo1, Elena Corradini, Francesca Ferrara, Alberto Vegetti, Gerard De Jong, Gian Luca Abbati, Pier Paolo Arcuri, Sara Martinelli, Emilio Cerofolini.   

Abstract

The ferroportin-related disorder is an increasingly recognized cause of hereditary iron overload. Based on the in vitro behavior of different ferroportin mutant subsets, it was suggested that different forms of the disorder might exist in humans. We used MRI to address this question in vivo in 22 patients from four different pedigrees carrying different ferroportin mutations: A77D, N144H, G80S and Val 162del. We found that, based on the iron status of spleen and bone macrophages, two different forms of the disease can be identified: a classic, common form, characterized by hepatocyte, splenic macrophage and bone marrow macrophage iron retention in patients carrying the A77D, G80S and Val 162del ferroportin variants; a rarer non-classic form, associated with liver iron overload but normal spleen and bone marrow iron content in patients with the N144H mutation. The two forms are likely caused by lack- or gain-of-protein function, respectively. Interestingly, in treated patients with the classic form, the spleen and the spine show appreciable iron accumulation even when serum ferritin is normal and liver iron content low. In conclusion, MRI is a useful non-invasive diagnostic tool to categorize and diagnose the disorder, monitor the status of iron depletion and gain insights on its natural history and management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052926     DOI: 10.1016/j.bcmd.2006.08.007

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  12 in total

1.  Liver iron concentration quantification by MRI: are recommended protocols accurate enough for clinical practice?

Authors:  Agustin Castiella; Jose M Alústiza; Jose I Emparanza; Eva Ma Zapata; Belen Costero; Maria I Díez
Journal:  Eur Radiol       Date:  2010-08-06       Impact factor: 5.315

2.  Novel assessment of hepatic iron distribution by synchrotron radiation X-ray fluorescence microscopy.

Authors:  Hisoka Kinoshita; Yuichi Hori; Takumi Fukumoto; Takuji Ohigashi; Kunio Shinohara; Yoshitake Hayashi; Yonson Ku
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

3.  Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond.

Authors:  Agustin Castiella; Eva Zapata; José M Alústiza
Journal:  World J Hepatol       Date:  2010-07-27

Review 4.  MR imaging assessment and quantification of liver iron.

Authors:  Manuela França; João Gomes Carvalho
Journal:  Abdom Radiol (NY)       Date:  2020-11

Review 5.  Pathology of hepatic iron overload.

Authors:  Yves Deugnier; Bruno Turlin
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

6.  Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.

Authors:  Roman Mayr; Andreas R Janecke; Melanie Schranz; William J H Griffiths; Wolfgang Vogel; Antonello Pietrangelo; Heinz Zoller
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

7.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

8.  Pediatric Ferroportin Disease.

Authors:  Gonzalo Galicia-Poblet; Ester Cid-París; Nerea López-Andrés; Alba Losada-Pajares; Juan-Carlos Jurado-López; María-Isabel Moreno-Carralero; María-Josefa Morán-Jiménez
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-12       Impact factor: 2.839

9.  Ferroportin disease mutations influence manganese accumulation and cytotoxicity.

Authors:  Eun-Kyung Choi; Trang-Tiffany Nguyen; Shigeki Iwase; Young Ah Seo
Journal:  FASEB J       Date:  2018-09-24       Impact factor: 5.834

Review 10.  Ferroportin disease: pathogenesis, diagnosis and treatment.

Authors:  Antonello Pietrangelo
Journal:  Haematologica       Date:  2017-11-03       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.